CLUSTER filed Aug 12, 2026 at 17:06 ET
Replimune insiders (CEO, CFO, CMO, CAO) sold $906K in open-market sales on August 10, 2026, the same day as a $150M dilutive offering priced at $12.06. The sales are small relative to the $1.1B market cap (0.08%), but the timing, coinciding with the offering, suggests insiders were selling into the offering price. Critically, Baker Brothers, a director and the company's largest holder, purchased $33M in open-market shares on August 11, 2026, at the offering price, signaling confidence in the post-dilution value. The cluster is mixed: C-suite sells are routine liquidity (likely 10b5-1 or tax-related), while Baker's massive buy is a strong bullish signal that partially offsets the dilution narrative.